English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Hemp, Inc. Reports Oklahoma Next to Allow Commercial Production of Industrial Hemp
Apr 19, 2019 01:00 HKT
ReShape Lifesciences Announces Distribution in Australia
Apr 18, 2019 20:00 HKT
Quantum dot imaging advances
Apr 16, 2019 16:00 HKT
NutraLife Biosciences, Inc. enters Joint Venture with Henning Trading LLC to Cultivate and Process Hemp for 2019 U.S. Grow Season
Apr 12, 2019 07:20 HKT
Tauriga Sciences, Inc. to Develop Airport Version of its CBD Infused Chewing Gum
Apr 10, 2019 06:00 HKT
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow
Apr 05, 2019 18:00 HKT
NutraLife Bioscience, Inc. Reports 2018 Year End Financial Results
Apr 04, 2019 05:00 HKT
Tauriga Sciences, Inc. Enters into Comprehensive Distribution Agreement to Establish its Tauri-Gum Brand in the New York City Metropolitan Area Market
Apr 02, 2019 05:00 HKT
中国生物制药2018年度业绩再创新高
Apr 01, 2019 22:03 HKT
中國生物製藥2018年度業績再創新高
Apr 01, 2019 22:02 HKT
Sino Biopharmaceutical's 2018 Annual Results Reaches New Height
Apr 01, 2019 22:01 HKT
Biolidics' Laboratory Partner in China to Offer Laboratory-Developed Cancer Tests Using Biolidics' ClearCell FX1 System and CTChip FR1 Biochips
Apr 01, 2019 16:00 HKT
Cambridge Innovation Capital完成1.5億歐元的新資本融資
Apr 01, 2019 15:00 HKT
Cambridge Innovation Capital完成1.5亿欧元的新资本融资
Apr 01, 2019 15:00 HKT
Cambridge Innovation Capital completes GBP150 million new capital raise
Apr 01, 2019 15:00 HKT
华康生物医学公布上市后首份全年业绩
Mar 26, 2019 09:39 HKT
華康生物醫學公布上市後首份全年業績
Mar 26, 2019 09:37 HKT
Huakang Biomed Announces First Annual Results Since Listing
Mar 26, 2019 09:36 HKT
藥明康德2018年業績保持強勢增長
Mar 25, 2019 20:43 HKT
药明康德2018年业绩保持强势增长
Mar 25, 2019 20:42 HKT
Next >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: